Chapter 12 - Investments ICE6: E12-22 Equity Method - Depreciation Adjustment Fizer Pharmaceutical paid $68 million on January 2, 2021, for 4 million shares of Carne Cosmetics common stock. The investment represents a 25% interest in the net assets of Came and gave Fizer the ability to exercise significant influence over Carne's operations. Fizer received dividends of Si per share on December 21, 2021. and Carne reported net income of $40 million for the year ended December 31, 2021. The fair value of Carne's common stock at December 31, 2021, was $18.50 per share. The book value of Came's net assets was $192 million. The fair value of Came's depreciable assets exceeded their book value by S32 million. These assets had an average remaining useful life of eight years. The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill. Prepare journal entries for Fizer for the following: Purchase of the stock Net income earned by Care Dividend paid by Care Adjustment for depreciation